(Q47801593)

5 February 2018

title

Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment (English)

1 reference

5 February 2018

1 reference

C J Tuck

1

1 reference

5 February 2018

K M Taylor

2

1 reference

5 February 2018

P R Gibson

3

1 reference

5 February 2018

J S Barrett

4

1 reference

5 February 2018

J G Muir

5

1 reference

5 February 2018

language of work or name

English

0 references

publication date

15 August 2017

1 reference

5 February 2018

The American Journal of Gastroenterology

published in

1 reference

5 February 2018

volume

113

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

124-134

1 reference

5 February 2018

An evidence-based position statement on the management of irritable bowel syndrome

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Irritable bowel syndrome: a clinical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Personal view: food for thought--western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Beneficial effects of oral tilactase on patients with hypolactasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Does oral α-galactosidase relieve irritable bowel symptoms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

A pilot trial on subjects with lactose and/or oligosaccharides intolerance treated with a fixed mixture of pure and enteric-coated α- and β-galactosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Fructan and free fructose content of common Australian vegetables and fruit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Further validation of the visual analogue scale for irritable bowel syndrome after use in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Adding glucose to food and solutions to enhance fructose absorption is not effective in preventing fructose-induced functional gastrointestinal symptoms: randomised controlled trials in patients with fructose malabsorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Pancreatic enzyme replacement therapy in chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Development and validation of a comprehensive semi-quantitative food frequency questionnaire that includes FODMAP intake and glycemic index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Poor reproducibility of breath hydrogen testing: Implications for its application in functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Intestinal Gas Capsules: A Proof-of-Concept Demonstration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

In vitro fermentation profiles, gas production rates, and microbiota modulation as affected by certain fructans, galactooligosaccharides, and polydextrose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

The effects of butyrate enemas on visceral perception in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Misreporting of energy and micronutrient intake estimated by food records and 24 hour recalls, control and adjustment methods in practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Design of clinical trials evaluating dietary interventions in patients with functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Re-challenging FODMAPs: the low FODMAP diet phase two.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

The Effect of Keeping Food Records on Eating Patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.245

Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance.

21 January 2018

1 reference

12 December 2020

Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans

1 reference

12 December 2020

Diets that differ in their FODMAP content alter the colonic luminal microenvironment

1 reference

12 December 2020

A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults

1 reference

12 December 2020

Comparative effects of exogenous lactase (?-galactosidase) preparations onin vivo lactose digestion

1 reference

12 December 2020

Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon

1 reference

12 December 2020

Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2017.245

1 reference

5 February 2018

PubMed ID

28809383

1 reference

5 February 2018